GE HealthCare Advances StarGuide GX for Theranostics
CHICAGO — September 8, 2026 GE HealthCare announced that its new StarGuide GX digital 4D CZT SPECT/CT system is...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CHICAGO — September 8, 2026 GE HealthCare announced that its new StarGuide GX digital 4D CZT SPECT/CT system is...
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonova™ Spectra photon-counting computed tomography (PCCT) system has received CE...
Chicago, Ill. – August 28, 2026 GE HealthCare announced three additions to its Vivid™ cardiovascular ultrasound portfolio — Vivid...
Chicago, USA – March 26, 2026 GE HealthCare announced a leading industrial role in the €50.5 million COMPASS consortium,...
CHICAGO, ILLINOIS, March 23, 2026 GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) has granted...
CHICAGO, Dec. 29, 2025 — GE HealthCare announced that its senior management team will present at an upcoming January...
